Skip to content
10-Q

Quarterly Report

ENDOLOGIX INC /DE/

0001013606-20-000094

← back to feed
Filed
May 27, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · May 18, 2020 19.17M sh
Capex Q1 2020 · Mar 31, 2020 $100K
Capex Q1 2020 · Mar 31, 2019 $107K
Operating Cash Flow Q1 2020 · Mar 31, 2020 −$9.32M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$13.66M
Long Term Debt Q1 2020 · Mar 31, 2020 $4.28M
Long Term Debt Q1 2020 · Dec 31, 2019 $172.06M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $40.85M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $41.56M
Cash And Equivalents Q1 2020 · Mar 31, 2019 $9.7M
Stockholders Equity Q1 2020 · Mar 31, 2020 $53.32M
Stockholders Equity Q1 2020 · Dec 31, 2019 $63.86M
Current Liabilities Q1 2020 · Mar 31, 2020 $229.16M
Current Liabilities Q1 2020 · Dec 31, 2019 $55.79M
Total Liabilities Q1 2020 · Mar 31, 2020 $247.03M
Total Liabilities Q1 2020 · Dec 31, 2019 $243.31M
Current Assets Q1 2020 · Mar 31, 2020 $88.52M
Current Assets Q1 2020 · Dec 31, 2019 $93.7M
Total Assets Q1 2020 · Mar 31, 2020 $300.35M
Total Assets Q1 2020 · Dec 31, 2019 $307.16M
Sga Expense Q1 2020 · Mar 31, 2020 $10.12M
Sga Expense Q1 2020 · Mar 31, 2019 $9.42M
Rd Expense Q1 2020 · Mar 31, 2020 $3.54M
Rd Expense Q1 2020 · Mar 31, 2019 $4.79M
Net Income Q1 2020 · Mar 31, 2020 −$18.12M
Net Income Q1 2020 · Mar 31, 2019 −$22.03M
Operating Income Q1 2020 · Mar 31, 2020 −$16.18M
Operating Income Q1 2020 · Mar 31, 2019 −$11.99M
Gross Profit Q1 2020 · Mar 31, 2020 $15.13M
Gross Profit Q1 2020 · Mar 31, 2019 $23.2M
Cost Of Revenue Q1 2020 · Mar 31, 2020 $13.38M
Cost Of Revenue Q1 2020 · Mar 31, 2019 $12.41M
Revenue Q1 2020 · Mar 31, 2020 $28.51M
Revenue Q1 2020 · Mar 31, 2019 $35.61M